Expert Outlook: Eastman Chemical Through The Eyes Of 5 Analysts
Portfolio Pulse from Benzinga Insights
Analyst ratings for Eastman Chemical (NYSE:EMN) have shown a mix of sentiments over the last quarter, with a recent shift towards a more positive outlook. The average 12-month price target for EMN has increased by 6.39% to $93.2, with a high estimate of $101.00 and a low of $89.00. Recent analyst actions, including several rating raises by firms such as UBS and Keybanc, reflect changing market dynamics and company performance. Despite facing a revenue decline of -16.32% as of 30 September 2023, Eastman Chemical demonstrates strong profitability and financial health, with impressive net margin, ROE, and ROA figures. However, its high debt-to-equity ratio suggests a higher level of financial risk.
February 02, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eastman Chemical's stock may see a positive short-term impact due to the recent analyst upgrades and increased price targets, reflecting a more optimistic outlook on the company's performance and market position.
The positive shift in analyst sentiment, highlighted by the increase in the average 12-month price target and several rating raises, suggests growing confidence in Eastman Chemical's market position and financial performance. Despite the revenue decline, the company's strong profitability indicators, such as net margin, ROE, and ROA, contribute to a positive outlook. However, the high debt-to-equity ratio is a concern that investors should monitor.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100